October 2021

The Comprehensive Management of Dravet Syndrome

November 25, 2021

NeurologyLive Peer Exchange

In a NeurologyLive® Insights series, experts in the diagnosis and treatment of Dravet syndrome discussed the management of the disease and the utilization of approved treatments to improve outcomes in patients.

The Therapeutic Space for People Living With Headache After COVID-19 Infection

November 22, 2021

Letter From the Editor

Although headache and COVID-19 have been linked together in the literature, more studies are needed to better understand the pathophysiology of these headaches and to determine the best treatment options.

Improving Stroke Systems of Care: A Tandem Role for Neurology and Primary Care Physicians

October 31, 2021

Clinical Viewpoint

Mitchell S. V. Elkind, MD, MS, MPhil, shared his perspective and offered insights into the recent updates from the American Heart Association/American Stroke Association on the landscape of stroke prevention and poststroke care.

S1P Receptor Modulation in Multiple Sclerosis

October 30, 2021

NeuroPathways

Continued improvement in the pharmacodynamics and pharmacokinetics of S1PR modulators, particularly in modulator-receptor selectivity, should improve therapeutic efficacy while reducing the potential for AEs.

A New Approach to Protein Misfolding in Parkinson Disease

October 30, 2021

Features

Previously, many promising treatments for PD have ultimately resulted in untenable adverse effects or in failure, but the evolving area of protein folding offers an opportunity to slow or reverse the neurodegenerative process.

Accessible Stroke Care for Diverse Populations: The Montefiore Approach

October 26, 2021

Features

Years of built-up trust in the community has enabled Montefiore’s Stern Stroke Center physicians to understand more about how stroke affects multicultural communities and to break down existing barriers to care.